‘No one has been more dedicated to increasing the pipeline of minority scholars...’
The American Society for Biochemistry and Molecular Biology has named Lovell Jones the winner of the society’s Ruth Kirschstein Diversity in Science Award. Jones is a professor at both the University of Texas MD Anderson Cancer Center and the University of Houston as well as director of the joint Center for Health Equity & Evaluation Research.
Throughout his career, Jones has focused on minority health issues. He was a co-founder of the Intercultural Cancer Council, the nation’s largest multicultural health policy group focused on minorities, the medically underserved and cancer; chaired the first Biennial Symposium on Minorities and Cancer in 1987; and was among the leaders who worked with members of Congress to designate the third week of every April National Minority Cancer Awareness Week.
—Lovell Jones
Thomas Landefeld, professor at California State University–Dominguez Hills, praised Jones for being “totally devoted to diversity issues in the scientific community, with a major emphasis on both addressing the underrepresentation of minorities at all levels in academia, industry and government, as well as the overwhelming issue of health disparities in our nation.”
Jones also has shown great dedication to mentorship of underrepresented groups. In supporting his nomination for the award, Marian Johnson-Thompson, professor emerita of the University of the District of Columbia, cited his “attention to promoting diversity in training programs, which has led to the next generation of health-disparities researchers and policy leaders.” Judith Kaur, from the Mayo Clinic, agreed: “No one has been more dedicated to increasing the pipeline of minority scholars than Lovell Jones.”
In addition to his efforts involving minority health disparities, Jones is also a pre-eminent scientist. He holds both M.S. and Ph.D. degrees in zoology from the University of California, Berkeley, and has worked in the department of biochemistry at MD Anderson since 1980, focusing primarily on the role of estrogen and environmental estrogenic agents in tumor induction in hormonally responsive tissues.
Jones received his award and delivered an award lecture during the Experimental Biology 2012 conference in San Diego.
About the award
The Ruth Kirschstein Diversity in Science Award was established to honor an outstanding scientist who has shown a strong commitment to the encouragement of underrepresented minorities to enter the scientific enterprise and/or to the effective mentorship of those within it. The award consists of a plaque, a cash prize of $3,000 and transportation expenses to present a lecture at the ASBMB annual meeting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Protein modifications drive lung cancer resistance
New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.